Teva gains favourable US court decision on generic Prevacid SoluTab
This article was originally published in Scrip
Executive Summary
The US Court of Appeals for the Federal Circuit has affirmed a November 10th, 2009, lower court decision that Teva Pharmaceutical Industries' generic version of Takeda's proton pump inhibitor Prevacid (lansoprazole) SoluTab does not infringe US patent No 5,464,632.